Click Therapeutics develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Their software, known as Digital Therapeutics™, leverages cognitive and neurobehavioral mechanisms to enable change within individuals. It can be used independently or in conjunction with biomedical treatments. Click's Clickometrics® adaptive data science platform personalizes user experience to optimize engagement and outcomes. They offer a smoking cessation program available nationwide and are conducting a phase III FDA registration trial for the treatment of Major Depressive Disorder. Click is also progressing a broad pipeline of Digital Therapeutics™ in various therapeutic areas, including Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, and more. For more information, visit ClickTherapeutics.com.